Pulmonx Corporation EPS - Earnings per Share 2019-2024 | LUNG
Pulmonx Corporation eps - earnings per share from 2019 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Pulmonx Corporation Annual EPS | |
|---|---|
| 2023 | $-1.60 |
| 2022 | $-1.59 |
| 2021 | $-1.35 |
| 2020 | $-3.16 |
| 2019 | $-11.66 |
| 2018 | $-11.03 |
| Pulmonx Corporation Quarterly EPS | |
|---|---|
| 2024-09-30 | $-0.36 |
| 2024-06-30 | $-0.39 |
| 2024-03-31 | $-0.36 |
| 2023-12-31 | $-0.36 |
| 2023-09-30 | $-0.39 |
| 2023-06-30 | $-0.43 |
| 2023-03-31 | $-0.42 |
| 2022-12-31 | $-0.38 |
| 2022-09-30 | $-0.38 |
| 2022-06-30 | $-0.40 |
| 2022-03-31 | $-0.43 |
| 2021-12-31 | $-0.36 |
| 2021-09-30 | $-0.28 |
| 2021-06-30 | $-0.36 |
| 2021-03-31 | $-0.35 |
| 2020-12-31 | $8.12 |
| 2020-09-30 | $-1.37 |
| 2020-06-30 | $-6.15 |
| 2020-03-31 | $-3.76 |
| 2019-12-31 | $0.00 |
| 2019-09-30 | $-2.41 |
| 2018-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||